Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Florian M.M. Baeres"'
Autor:
Wayne Weng, Sheldon X. Kong, Rahul Ganguly, Malene Hersloev, Jason Brett, Todd Hobbs, Florian M.M. Baeres
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 3, Iss 2, Pp n/a-n/a (2020)
Abstract Introduction The purpose of this study was to assess prevalence of atherosclerotic cardiovascular disease (ASCVD) according to number of affected vascular beds and the impact on healthcare utilization and costs in persons with type 2 diabete
Externí odkaz:
https://doaj.org/article/f6fa8730ee084226b9ceaef3718c1afc
Autor:
G. Kees Hovingh, Larry Lo, Mads D M Engelmann, Paul M. Ridker, Pablo Pergola, Florian M.M. Baeres, Peter Libby, Rescue Investigators, Milana Ivkovic, Michael H. Davidson, Matt Devalaraja, Dominic S. Raj, Douglas Kling
Publikováno v:
The Lancet, 397(10289), 2060-2069. Elsevier Limited
Background: IL-6 has emerged as a pivotal factor in atherothrombosis. Yet, the safety and efficacy of IL-6 inhibition among individuals at high atherosclerotic risk but without a systemic inflammatory disorder is unknown. We therefore addressed wheth
Autor:
RICHARD E. PRATLEY, FLORIAN M.M. BAERES, GEORGE BAKRIS, JACK LAWSON, KENNETH W. MAHAFFEY, JOHANNES F. MANN, HENRIETTE MERSEBACH, PETER ROSSING, KATHERINE R. TUTTLE, VLADO PERKOVIC
Publikováno v:
Diabetes. 71
Chronic kidney disease (CKD) is a common complication of type 2 diabetes (T2D) that increases the risk of kidney failure and cardiovascular (CV) disease. Data from CV outcomes trials suggest that glucagon-like peptide-1 receptor agonists have kidney-
Autor:
Antonio Ceriello, Alan M. Garber, Paola Fioretto, André Scheen, Jaakko Tuomilehto, Kamlesh Khunti, Peter J. Grant, Jyothis T. George, Jorge Plutzky, Wendy Gattis Stough, Lars Rydén, Anna Maria Langkilde, Faiez Zannad, Florian M.M. Baeres, Eberhard Standl, Francesco Cosentino
Publikováno v:
European Heart Journal. 40:2907-2919
Autor:
Michael A. Nauck, Neil R Poulter, Anne B. Thomsen, Florian M.M. Baeres, Bryan Goldman, Stephen C. Bain, Steven P. Marso, John B. Buse, Mansoor Husain, Leader Trial Investigators, Richard E. Pratley
Background More data regarding effects of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes (T2D) and heart failure (HF) are required. Objectives The purpose of this study was to investigate the effects of liraglutide on card
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::252b7e009e6579b9c46ad4a5798a9a26
https://cronfa.swan.ac.uk/Record/cronfa53055/Download/53055__16138__2614012bea8e49fab045df97b4fcdd98.pdf
https://cronfa.swan.ac.uk/Record/cronfa53055/Download/53055__16138__2614012bea8e49fab045df97b4fcdd98.pdf
Autor:
Kirstine Brown-Frandsen, Lasse Steen Ravn, Steven P. Marso, Peter Lommer Kristensen, Florian M.M. Baeres, Søren Rasmussen, Stuart J. Pocock, William M. Steinberg, JF Mann, Gilbert H. Daniels, Richard M. Bergenstal, John B. Buse, Steven E. Nissen, J Lüdemann, Stephan Jacob, Mette Stockner, Neil R Poulter, B. Zinman, Michael A. Nauck, M Rieck
Publikováno v:
Diabetologie und Stoffwechsel. 12:S1-S84
Publikováno v:
Journal of Diabetes and its Complications. 34:107500
To assess longitudinal risk for atherosclerotic cardiovascular disease (ASCVD) and cost of healthcare resource utilization over 9 years in patients with or without newly diagnosed type 2 diabetes (T2DM) who had no ASCVD at baseline.This retrospective
Autor:
Bryan Goldman, Steven P. Marso, Leader Trial Investigators, Stephen C. Bain, Michael A. Nauck, Neil R Poulter, Florian M.M. Baeres, Mansoor Husain, Johannes F.E. Mann, A. Bloch Thomsen
Publikováno v:
European Heart Journal. 39
Autor:
Todd Hobbs, Wayne Weng, Malene Hersloev, Rahul Ganguly, Sheldon X. Kong, Florian M.M. Baeres, Jason Brett
Publikováno v:
Journal of the American College of Cardiology. 73:1759
Atherosclerotic cardiovascular disease (ASCVD) is a major cause of morbidity and mortality in patients with type 2 diabetes (T2D). Real-world claims data were used to assess the prevalence of established ASCVD by vascular bed in patients with T2D. Th
Autor:
T Wehrhahn, Stephen C. Bain, J Gross, Florian M.M. Baeres, J House, Morten Donsmark, Stephan Jacob, Steven P. Marso, I Caterson, A Salisbury
Publikováno v:
Diabetologie und Stoffwechsel. 11